The Nrf2 signaling pathway demonstrates a high prevalence of activation across various cancer types (Table 1), where it orchestrates tumorigenesis and progression through multifaceted mechanisms including but not limited to antioxidant defense regulation, metabolic reprogramming, and chemotherapy resistance development. This evidence concerns the gene NFE2L2 and cancer.